Pharmacokinetics of EF5 [2-(2-nitro-1- H -imidazol-1-yl)- N -(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles - Concepedia

Concepedia

Publication | Closed Access

Pharmacokinetics of EF5 [2-(2-nitro-1- H -imidazol-1-yl)- N -(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles

66

Citations

0

References

2001

Year

C. J. Koch, S.M. Hahn, K. Rockwell, Joseph M. Covey, W. Gillies McKenna, Sydney M. Evans

Cancer Chemotherapy and Pharmacology

Hypoxia MeasurementsPharmacological Study2-Nitro-1- H -Imidazol-1-ylMedicineHypoxia (Medicine)ToxicologyPharmacologyPharmacokineticsHuman PatientsOxidative Stress

No additional data available for this publication yet. Check back later!